30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Quarterly Review

2Q14 Revenue: CONMED

$102.4MM, +0.8%

  • Powered instrument handpieces +12%
  • Shoulder repair devices +10%
  • Sports tissue/biologic product sales decreased ~$1.3MM following contract supplier’s inability to supply platelet-rich plasma products for resale; will likely not be able to see product in near term
  • Expecting 2H U.S. launch for Edge Ablation bipolar radiofrequency arthroscopic energy system for use in shoulder, knee, hip and extremity procedures